public offering Archives | Be Korea-savvy
Constellation Brands Prices Offering of Senior Notes

Constellation Brands Prices Offering of Senior Notes

VICTOR, N.Y., July 24 (Korea Bizwire) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today that it priced the public offering of $800.0 million of 3.150% Senior Notes due 2029 (the “2029 notes”) for a public offering price of 99.957% of the principal amount of the 2029 notes. The 2029 notes will be [...]

Nanobiotix Plans to Conduct Registered Public Offering in the United States

Nanobiotix Plans to Conduct Registered Public Offering in the United States

Paris, France and Cambridge, Massachusetts, Jan. 16 (Korea Bizwire) – NANOBIOTIX SA (Euronext : NANO – ISIN : FR0011341205) announced today that it plans to conduct a registered public offering of its ordinary shares, including in the form of American Depositary Shares (ADSs) in the United States, and has confidentially submitted a draft registration statement [...]

Williams Scotsman Announces Pricing of Upsized Common Stock Offering

Williams Scotsman Announces Pricing of Upsized Common Stock Offering

BALTIMORE, Jul. 26 (Korea Bizwire) — WillScot Corporation (Nasdaq:WSC) (“WillScot”), a specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced the pricing of an underwritten public offering (the “Offering”) of 8,000,000 shares of its Class A common stock, par value $0.0001 (“Common Stock”) at a price [...]

Constellation Brands Announces Full Redemption of 6.000% Senior Notes Due 2022

Constellation Brands Announces Full Redemption of 6.000% Senior Notes Due 2022

VICTOR, N.Y., Jan. 29 (Korea Bizwire) — Constellation Brands, Inc. (NYSE:STZ) (NYSE:STZ.B), a leading beverage alcohol company, announced today that it has given notice for full redemption prior to maturity of all of its outstanding 6.000% Senior Notes due 2022 (CUSIP Number:  21036PAH1) (the “notes”) to be effected on February 28, 2018 (the “redemption date”). As of [...]

Constellation Brands Prices Offering of Senior Notes

Constellation Brands Prices Offering of Senior Notes

VICTOR, N.Y., Jan. 29 (Korea Bizwire) — Constellation Brands, Inc. (NYSE:STZ) (NYSE:STZ.B), a leading beverage alcohol company, announced today that it priced the public offering of $1.9 billion aggregate principal amount of Senior Notes, consisting of (i)  $600.0 million of 3.200% Senior Notes due 2023 (the “2023 notes”) for a public offering price of 99.907% of [...]

GW Pharmaceuticals Announces Proposed Public Offering of ADSs

GW Pharmaceuticals Announces Proposed Public Offering of ADSs

LONDON, Dec. 5 (Korea Bizwire) — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today that it intends to sell, subject to market and other conditions, $225 million of American Depositary Shares (“ADSs”) representing ordinary shares of [...]

RedHill Biopharma Announces Closing of Public Offering of its American Depositary Shares

RedHill Biopharma Announces Closing of Public Offering of its American Depositary Shares

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 13 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal and inflammatory diseases and cancer, today announced the closing of its previously announced underwritten public offering of [...]

RedHill Biopharma Prices Public Offering of its American Depositary Shares

RedHill Biopharma Prices Public Offering of its American Depositary Shares

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 8 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal and inflammatory diseases and cancer, today announced the pricing of its previously announced underwritten public offering for [...]

RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares

RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 7 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal and inflammatory diseases and cancer, today announced that it intends to offer its American Depositary Shares (“ADSs”), [...]